Fidia completes establishment of its operations and seeks further growth opportunities in North America

PARSIPPANY, N.J. & ABANO TERME, Italy July 07, 2014 — Fidia Pharma USA Inc., a wholly-owned subsidiary of Fidia Farmaceutici SpA, an international integrated company and recognized leader in hyaluronic acid-based products, announced today the completion of the establishment of its operations in the United States. Effective July 2014, the company’s sales force, previously operating […]

Read More

FIDIA Farmaceutici to Attend the 32nd Annual J.P. Morgan Investors Healthcare Conference

ABANO TERME, Italy and PARSIPPANY, New Jersey, January 6, 2014 /PRNewswire/ — FIDIA Farmaceutici S.p.A., the Italian pharmaceutical company leader in hyaluronic acid (HY) – based products, announced today that they will be present at the 32nd Annual J. P. Morgan Investors Healthcare Conference. The conference will take place on Monday, January 13, 2014, through […]

Read More

Our Four Leading Principles: